SCHEMBL9686533

SCHEMBL9686533

COCOc1cccnc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
LTA4H P09960 1/20 0.56
MAPK14 Q16539 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 1/20 0.47
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
PLAU P00749 1/20 0.39
MET P08581 1/20 0.38
AKT1 P31749 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NAPRT Q6XQN6 1/20 0.36
BACE1 P56817 1/20 0.35
PTPN1 P18031 1/20 0.35
NSD2 O96028 1/20 0.35
CASP6 P55212 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10560687 0.87 LTA4H (0.56) NPC1RAB9ALTA4HMAPK14SMN1; SMN2
SCHEMBL3665962 0.83 RAB9A (0.55) NPC1RAB9ALTA4HMAPK14SMN1; SMN2
SCHEMBL1002382 0.80 LTA4H (0.59) NPC1RAB9ALTA4HMAPK14SMN1; SMN2
SCHEMBL10562118 0.80 NPC1 (0.59) NPC1RAB9ALTA4HMAPK14SMN1; SMN2
SCHEMBL9890 0.79
SCHEMBL16237691 0.78 CHRNB2 (0.47) NPC1RAB9APLAUPTPN1DCPS
Bromide SCHEMBL5755866 0.78 RAB9A (0.57) NPC1RAB9ALTA4HMAPK14SMN1; SMN2
SCHEMBL16054964 0.77 CHRNB4 (0.50) NPC1RAB9ASMN1; SMN2PLAUL3MBTL1
SCHEMBL1445524 0.77 S1PR4 (0.47) NPC1RAB9ASMN1; SMN2HTTPLAU
SCHEMBL1921438 0.77 LTA4H (0.56) NPC1RAB9ALTA4HMAPK14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102443009-B Fused ring kinase inhibitor KBP BIOSCIENCES CO LTD 2014-04-16 CN disclosed
CN-102443009-A Fused ring kinase inhibitors KBP BIOSCIENCES CO LTD 2012-05-09 CN disclosed
EP-0268989-B1 IMIDAZOPYRIDINE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-07-08 EP disclosed
US-4831041-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
US-4782055-A Imidazopyridine compounds useful in the treatment of ulcers FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
CN-87108027-A Imidazopyridine and preparation method thereof 1988-06-08 CN disclosed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP disclosed
EP-0228006-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-07-08 EP disclosed